17.75
1.93%
-0.35
アフターアワーズ:
16.87
-0.88
-4.96%
Travere Therapeutics Inc (TVTX) 財務データ
損益計算書
四半期ごと
*すべての数値は百万単位です
期間終了日 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
期間の長さ | 3 か月 | 3 か月 | 3 か月 | 3 か月 | 3 か月 |
Revenues |
8.18%
41.37
|
45.06 | 37.09 | 32.20 | 30.89 |
Cost Of Revenue |
67.05%
1.504
|
4.564 | 1.289 | 1.99 | 5.125 |
Gross Profit |
1.54%
39.87
|
40.49 | 35.81 | 57.71 | 51.87 |
Operating Expenses
|
28.58%
179.11
|
139.29 | 129.68 | 136.15 | 128.26 |
Interest Income/Expense |
0.00%
2.80
|
2.80 | 2.80 | 2.90 | 2.90 |
Benefits Costs and Expenses |
32.60%
177.14
|
133.59 | 126.32 | 134.06 | 127.37 |
Costs And Expenses |
29.66%
180.61
|
139.29 | 129.68 | 136.15 | 128.26 |
Operating Income/Loss |
47.76%
-139.24
|
-94.23 | -92.58 | -103.95 | -97.37 |
Nonoperating Income/Loss |
39.18%
3.47
|
5.705 | 3.356 | 2.016 | 0.793 |
Income/Loss From Continuing Operations Before Tax |
53.36%
-135.77
|
-88.53 | -89.23 | -101.87 | -96.49 |
Income Tax Expense/Benefit |
180.88%
0.191
|
0.068 | 0.012 | 0.065 | 0.078 |
Income/Loss From Continuing Operations After Tax |
53.46%
-135.96
|
-88.60 | -89.24 | -101.93 | -96.56 |
Income/Loss From Discontinued Operations, Net Of Tax |
93.47%
-0.103
|
-1.577 | 239.98 | 16.30 | 10.23 |
Net Income/Loss
|
50.89%
-136.06
|
-90.17 | 150.74 | -85.63 | -86.33 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Average Shares |
10,271%
77.14
|
0.7438 | 76.31 | 76.00 | 68.17 |
Diluted Average Shares |
10,271%
77.14
|
0.7438 | 76.31 | 76.00 | 68.17 |
Basic Earnings Per Share |
49.15%
-1.76
|
-1.18 | 1.97 | -1.13 | -1.27 |
Diluted Earnings Per Share |
49.15%
-1.76
|
-1.18 | 1.97 | -1.13 | -1.27 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
大文字化:
|
ボリューム (24 時間):